XOMA Corp

NASDAQ XOMAP

Data sourced from iex and EODHD
Download Data

XOMA Corp Long-Term Assets (Other) for the year ending December 31, 2023: USD 533.00 K

XOMA Corp Long-Term Assets (Other) is USD 533.00 K for the year ending December 31, 2023, a -99.17% change year over year. Long-Term Assets (Other) are long-term assets that are not classified under property, plant, equipment, intangible assets, or investments.
  • XOMA Corp Long-Term Assets (Other) for the year ending December 31, 2022 was USD 63.94 M, a 21,143.52% change year over year.
  • XOMA Corp Long-Term Assets (Other) for the year ending December 31, 2021 was USD 301.00 K, a -99.14% change year over year.
  • XOMA Corp Long-Term Assets (Other) for the year ending December 31, 2020 was USD 35.15 M, a 1.80% change year over year.
  • XOMA Corp Long-Term Assets (Other) for the year ending December 31, 2019 was USD 34.53 M.
NASDAQ: XOMAP

XOMA Corp

CEO -
IPO Date Dec. 16, 2020
Location United States
Headquarters 2200 Powell Street, EmeryVille, CA, United States, 94608
Employees 13
Sector Healthcare
Industry Biotechnology
Description

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Similar companies

XOMAO

XOMA Corporation

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email